Relationship between nonphenacetin combined analgesics and nephropathy: A review

Kidney International

Volumn 58, Issue 6, 2000, Pages 2259-2264

  Feinstein, Alvan R ^{a,b,c,d,e,f,g,h,i,j,k}   Heinemann, Lothar A J ^{a,b,c,d,e,f,g,h,i,j,k}   Curhan, Gary C ^{a,b,c,d,e,f,g,h,i,j,k}   Delzell, Elizabeth ^{a,b,c,d,e,f,g,h,i,j,k}   DeSchepper, Paul J ^{a,b,c,d,e,f,g,h,i,j,k}   Fox, Johannes M ^{a,b,c,d,e,f,g,h,i,j,k}   Graf, Helmut ^{a,b,c,d,e,f,g,h,i,j,k}   Luft, Friedrich C ^{a,b,c,d,e,f,g,h,i,j,k}   Michielsen, Paul ^{a,b,c,d,e,f,g,h,i,j,k}   Mihatsch, Michael J ^{a,b,c,d,e,f,g,h,i,j,k}   Suissa, Samy ^{a,b,c,d,e,f,g,h,i,j,k}   Van Der Woude, Fokko ^{a,b,c,d,e,f,g,h,i,j,k}   Willich, Stefan ^{a,b,c,d,e,f,g,h,i,j,k}  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Ctr for Epidemiol and Hlth Res   (Germany)

^c HARVARD UNIVERSITY   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f MERZ PHARMACEUTICALS GMBH   (Germany)

^g KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^h HUMBOLDT UNIVERSITY   (Germany)

ⁱ UNIVERSITY HOSPITAL BASEL   (Switzerland)

^j MCGILL UNIVERSITY   (Canada)

^k UNIVERSITY OF HEIDELBERG   (Germany)

more..

Author keywords

Analgesic associated nephropathy; Combined analgesics; End stage renal failure; Nonphenacetin analgesics; Renal toxicity

Indexed keywords

ANALGESIC AGENT; PHENACETIN;

DRUG EXPOSURE; DRUG INDUCED DISEASE; HISTOPATHOLOGY; HUMAN; KIDNEY CALCIFICATION; KIDNEY DISEASE; KIDNEY FAILURE; NEPHROTOXICITY; PRIORITY JOURNAL; REVIEW;

EID: 0033671352     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00410.x     Document Type: Article

References (24)

1. A long-term prospective controlled study of analgesic abuse in Belgium
2. Epidemiologic study of abuse of analgesics containing phenacetin: Renal morbidity and mortality (1968-1979)
3. Regular analgesic intake and the risk of end-stage renal failure
4. End-stage renal disease and non-narcotic analgesics: A case-control study
5. Epidemiologic study of regular analgesic use and end-stage renal disease
6. Is phenacetin responsible for analgesic nephropathy in New South Wales?
7. Analgesic use and chronic renal disease
8. Occupational and other exposures associated with male end-stage renal disease: A case-control study
9. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs
10. Analgesic nephropathy in Belgium is related to the sales of particular analgesic mixtures
11. Analgesic nephropathy
12. Combination analgesic involvement in the pathogenesis of analgesic nephropathy: The European perspective
13. Analgesic nephropathy
14. Differential distribution of the mixed-function oxidase activities in rabbit kidney
15. Metabolism of paracetamol to a glutathione conjugate catalyzed by prostaglandin synthetase
16. Metabolic activation of acetaminophen (paracetamol) mediated by cytochrome P-450 mixed function oxidase and prostaglandin endoperoxidase synthetase in rabbit kidney
17. Effects of acetylsalicylic acid and paracetamol alone and in combination on prostanoid synthesis in man
18. Carcinogenicity of analgesics: Long-term treatment of Sprague-Dawley rats with phenacetin, phenazon, caffeine and paracetamol (acetaminophen)
19. Eighteen month oral study of aspirin, phenacetin and caffeine in C57 BL/6 mice
20. Chronic effect of analgesics on the kidney
21. Do caffeine-containing analgesics promote dependence? A review and evaluation